Showing 261-280 of 746 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Diazepam for treating tetanus
Cochrane Systematic Reviews, 26-Jan-2004
Clinical management of the muscle spasms and rigidity of tetanus poses a difficult therapeutic problem to physicians everywhere, especially in resource poor countries. There are wide variations in therapeutic regimens commonly used in clinical practice du
- Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Cochrane Systematic Reviews, 23-Jan-2008
Several dietary factors have been considered to be involved in the increasing incidence of colorectal cancer in industrialised countries. Experimental and epidemiological evidence has been suggestive but not conclusive for a protective role for high dieta
- Dietary supplements for dysmenorrhoea
Cochrane Systematic Reviews, 22-Mar-2016
Dysmenorrhoea refers to painful menstrual cramps and is a common gynaecological complaint. Conventional treatments include non-steroidal anti-inflammatory drugs (NSAIDs) and oral contraceptive pills (OCPs), which both reduce myometrial activity (contracti
- Digitalis for treatment of heart failure in patients in sinus rhythm
Cochrane Systematic Reviews, 28-Apr-2014
Digitalis glycosides have been in clinical use for the treatment of heart failure (HF) for longer than 200 years. In recent years, several trials have been conducted to address concerns about their efficacy and toxicity.
- Dipyridamole for preventing stroke and other vascular events in patients with vascular disease
Cochrane Systematic Reviews, 2-Aug-2010
Patients with limited cerebral ischaemia of arterial origin are at risk of serious vascular events (4% to 11% annually). Aspirin reduces that risk by 13%. In one trial, adding dipyridamole to aspirin was associated with a 22% risk reduction compared with
- Diuretic therapy for newborn infants with posthemorrhagic ventricular dilatation
Cochrane Systematic Reviews, 23-Apr-2001
Intraventricular hemorrhage remains a serious complication of premature birth and post-hemorrhagic hydrocephalus still has no satisfactory treatment. Acetazolamide and furosemide, which both reduce the production of cerebrospinal fluid, have been suggeste
- Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease
Cochrane Systematic Reviews, 7-Sep-2011
Lung disease in preterm infants is often complicated with lung edema.
- Diuretics for heart failure
Cochrane Systematic Reviews, 12-Mar-2019
Chronic heart failure is a major cause of morbidity and mortality worldwide. Diuretics are regarded as the first-line treatment for patients with congestive heart failure since they provide symptomatic relief. The effects of diuretics on disease progressi
- Diuretics for Ménière's disease or syndrome
Cochrane Systematic Reviews, 9-Mar-2010
This is an update of a review first published in The Cochrane Library Issue 3, 2006.
- Diuretics for preventing pre-eclampsia
Cochrane Systematic Reviews, 14-Jun-2010
Diuretics are used to reduce blood pressure and oedema in non-pregnant individuals. Formerly, they were used in pregnancy with the aim of preventing or delaying the development of pre-eclampsia. This practice became controversial when concerns were raised
- Diuretics for respiratory distress syndrome in preterm infants
Cochrane Systematic Reviews, 7-Dec-2011
Lung edema may complicate respiratory distress syndrome (RDS) in preterm infants.
- Diuretics for transient tachypnoea of the newborn
Cochrane Systematic Reviews, 21-Nov-2015
Transient tachypnoea of the newborn (TTN) results from delayed clearance of lung liquid and is a common cause of admission of full-term infants to neonatal intensive care units. The condition is particularly common after elective caesarean section. Conven
- Doxapram versus methylxanthine for apnea in preterm infants
Cochrane Systematic Reviews, 25-Feb-2013
Recurrent apnea is common in preterm infants, particularly at very early gestational ages. These episodes of loss of effective breathing can lead to hypoxemia and bradycardia which may be severe enough to require resuscitation including use of positive pr
- Drug treatment for facioscapulohumeral muscular dystrophy
Cochrane Systematic Reviews, 19-Apr-2004
Facioscapulohumeral muscular dystrophy is a progressive muscle disease which has no agreed treatment. Early suggestions that corticosteroids might be helpful were not supported by a subsequent open label study. The beta 2 adrenergic agonist albuterol, als
- Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics)
Cochrane Systematic Reviews, 12-Dec-2012
Enuresis (bedwetting) is a socially stigmatising and stressful condition which affects around 15% to 20% of five-year olds and up to 2% of young adults. Although there is a high rate of spontaneous remission, the social, emotional and psychological costs
- Drugs for treating paracoccidioidomycosis
Cochrane Systematic Reviews, 19-Apr-2006
Paracoccidioidomycosis is a fungal infection that occurs only in some particular places in Latin America. Treatment is long, the drugs have side effects, and patients can relapse. However, the disease is potentially fatal.
- Drugs versus placebo for dysthymia
Cochrane Systematic Reviews, 18-Jun-2015
Dysthymia is a depressive disorder of chronic nature but of lower severity than major depression. Depressive symptoms are more or less continuous for at least two years. Patients with this disorder experience considerable social dysfunction and disability
- Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
Cochrane Systematic Reviews, 23-Oct-2015
Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive disorders, urinary stress incontinence and the management of neuropathic pain associated with diabetic peripheral neuropathy. A number o
- Duration of antibacterial treatment for uncomplicated urinary tract infection in women
Cochrane Systematic Reviews, 28-Sep-2008
Uncomplicated urinary tract infection (UTI) is a common disease, occurring frequently in young sexually active women. In the past, seven day antibiotic therapy was recommended while the current practice is to treat uncomplicated UTI for three days.
- Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants
Cochrane Systematic Reviews, 21-Oct-2021
Bronchopulmonary dysplasia (BPD) remains a major problem for infants born extremely preterm. Persistent inflammation in the lungs is important in its pathogenesis. Systemic corticosteroids have been used to prevent or treat BPD because of their potent ant
